Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis-Reference-Cited by-同舟云学术

Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis

Published:2006 Issue:9 Volume:54 Page:2830-2839
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis Rheum

Author:

Wessels Judith A. M.,Kooloos Wouter M.,Jonge Robert De,De Vries-Bouwstra Jeska K.,Allaart Cornelia F.,Linssen Annelies,Collee Gerard,Sonnaville Peter De,Lindemans Jan,Huizinga Tom W. J.,Guchelaar Henk-Jan

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Reference50 articles.

1. Factors predicting response to treatment in rheumatoid arthritis: The importance of disease duration

2. Long-Term Outcomes in Rheumatoid Arthritis

3. The rheumatoid arthritis patient in the clinic: comparing more than 1300 consecutive DMARD courses

4. Therapeutic strategies in early rheumatoid arthritis

5. Treatment of Rheumatoid Arthritis with Methotrexate Alone, Sulfasalazine and Hydroxychloroquine, or a Combination of All Three Medications

Cited by 112 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A meta-analysis of the association between the ATIC 347 C/G polymorphism and methotrexate responsiveness and toxicity in rheumatoid arthritis;Seminars in Arthritis and Rheumatism;2024-02

2. Genetic polymorphisms and Methotrexate response in patients with rheumatoid arthritis;Journal of Research in Pharmacy;2024

3. Drs. Bessette and Kinch reply;The Journal of Rheumatology;2022-10-15

4. Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? – A Case Report;Pharmacogenomics and Personalized Medicine;2022-05

5. Biomarkers to Predict DMARDs Efficacy and Adverse Effect in Rheumatoid Arthritis;Frontiers in Immunology;2022-03-28